使用新型亲水导丝对慢性冠状动脉闭塞病变进行再通治疗。

Recanalization of chronic coronary occlusions using a new hydrophilic guidewire.

作者信息

Corcos T, Favereau X, Guérin Y, Toussaint M, Ouzan J, Zheng H, Pentousis D

机构信息

Department of Interventional Cardiology, Centre Médico-Chirurgical Parly Grand-Chesnay, Le Chesnay, France.

出版信息

Cathet Cardiovasc Diagn. 1998 May;44(1):83-90. doi: 10.1002/(sici)1097-0304(199805)44:1<83::aid-ccd20>3.0.co;2-p.

DOI:10.1002/(sici)1097-0304(199805)44:1<83::aid-ccd20>3.0.co;2-p

PMID:9600531

Abstract

Chronic total occlusion remains a relative contraindication and the main cause of failure of coronary angioplasty. Previously available hydrophilic guidewires had numerous limitations. The Crosswire is a new 0.014" hydrophilic nitinol guidewire which can be accommodated by very-low-profile balloon catheters and has a shapeable and highly radiopaque platinum-iridium coiled tip. This guidewire was used in 55 patients with 56 chronic coronary occlusions in which recanalization by conventional guidewires had failed. Clinical success was 79%. Coronary perforation occurred in two cases, one of them requiring pericardiocentesis for tamponade. These results illustrate the usefulness of this new guidewire in the treatment of chronic total occlusions.

摘要

慢性完全闭塞仍然是冠状动脉成形术的相对禁忌证和主要失败原因。以前可用的亲水导丝有许多局限性。Crosswire是一种新型的0.014英寸亲水镍钛合金导丝，可通过极薄型球囊导管使用，其尖端为可塑形且具有高显影性的铂铱合金线圈。该导丝用于55例患者的56处慢性冠状动脉闭塞病变，这些病变使用传统导丝未能实现再通。临床成功率为79%。发生了2例冠状动脉穿孔，其中1例需要心包穿刺引流进行心包填塞。这些结果表明这种新型导丝在慢性完全闭塞病变治疗中的有效性。